Recent Finacing
Recent Raise
Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company developing TP-03, a topical ophthalmic therapy targeting Demodex for blepharitis, with additional eye-care and clinical-stage programs.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Tarsus Pharmaceuticals.
